Tag Archives: Bill

Kaiser to reveal detailed financials under newly-signed California bill

Dive Brief: California Governor Gavin Newsom (D) signed a bill into law Thursday mandating greater transparency in Kaiser Permanente’s financial disclosures as income for the not-for-profit integrated health system continues to soar. Starting in 2020, Kaiser must break out expenses and revenue for its hospitals on a per-facility basis, revenue by type of payer, and rate… Read More »

Daily on Healthcare: Ted Cruz bill would speed FDA approval of drugs OK’d in other countries

Subscribe today to the Washington Examiner magazine and get Washington Briefing: politics and policy stories that will keep you up to date with what’s going on in Washington. SUBSCRIBE NOW: Just $ 1.00 an issue! TED CRUZ BILL WOULD SPEED FDA APPROVAL OF DRUGS OK’D IN OTHER COUNTRIES: Drugs and medical devices that have been… Read More »

Bernie Sanders leans into socialist label, touts ‘economic bill of rights’

Vermont Sen. Bernie Sanders, a 2020 Democratic presidential candidate, on Wednesday outlined his vision for a new “21st century economic bill of rights,” a key element of the socialist platform he has long championed. Sanders’ remarks, during a Wednesday afternoon at George Washington University, cements his presidential bid as the most left-wing of a sprawling,… Read More »

Wyden introduces price transparency bill targeting payers

Dive Brief: Senate Finance Committee Ranking Member Ron Wyden, D-Ore., introduced a bill Wednesday that would require health insurers to tell beneficiaries what the out-of-pocket costs would be for any in-network procedure or prescription drug they seek. The Health Care Price Check Act stipulates that commercial insurers, as well as Medicare plans, provide an online tool… Read More »

As drug prices took daily fire last year, PhRMA racked up a record lobbying bill

Between President Trump on Twitter and critics in Congress, pharma and its pricing faced daily fire last year. But the industry’s top lobbyists shot back—and shelled out a record amount of cash to do it. The Pharmaceutical Research and Manufacturers of America (PhRMA) spent a little over $ 27.5 million on lobbying in Washington last year,… Read More »